Abstract:Exposure to particulate matter (PM) has been linked to metabolic diseases. However, the effects of PM with an aerodynamic diameter ≤ 1.0 µm (PM1) on metabolic diseases remain unclear. This study is aimed at assessing the associations of PM1 with metabolic disease risk and quantifying the concentration-response (C-R) relationship of PM1 with metabolic disease risk. A national cross-sectional study was conducted, including 12,495 middle-aged and older adults in 123 Chinese cities. The two-year average concentration of PM1 was evaluated using satellite-based spatiotemporal models. Metabolic diseases, including abdominal obesity, diabetes, hypertension, dyslipidemia, and metabolic syndrome, were identified based on physical examination, blood standard biochemistry examination, and self-reported disease histories. Generalized linear models and C-R curves were used to evaluate the associations of PM1 with metabolic diseases. A total of 12,495 participants were included in this study, with a prevalence of 45.73% for abdominal obesity, 20.22% for diabetes, 42.46% for hypertension, 41.01% for dyslipidemia, and 33.78% for metabolic syndrome. The mean ± standard deviation age of participants was 58.79 ± 13.14 years. In addition to dyslipidemia, exposure to PM1 was associated with increased risks of abdominal obesity, diabetes, hypertension, and metabolic syndrome. Each 10 μg/m3 increase in PM1 concentrations was associated with 39% (odds ratio (OR) = 1.39, 95% confidence interval (CI) 1.33, 1.46) increase in abdominal obesity, 18% (OR = 1.18, 95%CI 1.12, 1.25) increase in diabetes, 11% (OR = 1.11, 95%CI 1.06, 1.16) increase in hypertension, and 25% (OR = 1.25, 95%CI 1.19, 1.31) in metabolic syndrome, respectively. C-R curves showed that the OR values of abdominal obesity, diabetes, hypertension, and metabolic syndrome were increased gradually with the increase of PM1 concentrations. Subgroup analysis indicated that exposure to PM1 was associated with increased metabolic disease risks among participants with different lifestyles and found that solid fuel users were more susceptible to PM1 than clean fuel users. This national cross-sectional study indicated that exposure to higher PM1 might increase abdominal obesity, diabetes, hypertension, and metabolic syndrome risk, and solid fuel use might accelerate the adverse effects of PM1 on metabolic syndrome risk. Further longitudinal cohort studies are warranted to establish a causal inference between PM1 exposure and metabolic disease risk.

Multiple categories of polycyclic aromatic hydrocarbons in atmospheric PM2.5 associated with changes in lipid profiles: A longitudinal study in Beijing

Lipidomics Insight into Chronic Exposure to Ambient Air Pollution in Mice

Associations of personal PM2.5 and PM2.5-Bound polycyclic aromatic hydrocarbons exposure with blood lipid profiles: A panel study from middle-aged Chinese adults

Determinating associations between multiple air pollutants and lipid peroxidation within elderlys in China

Association of Long-term Exposure to PM2.5 with Blood Lipids in the Chinese Population: Findings from a Longitudinal Quasi-experiment

Inflammatory biomarkers mediate the association between polycyclic aromatic hydrocarbon exposure and dyslipidemia: A national population-based study

Changes in Lipid Profiles and Blood Pressure in Response to Acute Exposure to Ambient PM2.5 and Its Carbonaceous Compositions - Results from the AIRLESS Study

Long-term PM0.1 exposure and human blood lipid metabolism: New insight from the 33-community study in China

Assessment of the temporal variability and health risk of atmospheric particle-phase polycyclic aromatic hydrocarbons in a northeastern city in China

Longitudinal relationships of polycyclic aromatic hydrocarbons exposure and genetic susceptibility with blood lipid profiles

Association between polycyclic aromatic hydrocarbon exposure and blood lipid levels: the indirect effects of inflammation and oxidative stress

Changes in Bioactive Lipid Mediators in Response to Short-Term Exposure to Ambient Air Particulate Matter: A Targeted Lipidomic Analysis of Oxylipin Signaling Pathways.

PM2.5-bound Polycyclic Aromatic Hydrocarbons (pahs) in Beijing: Seasonal Variations, Sources, and Risk Assessment.

Increased mortality risk from airborne exposure to polycyclic aromatic hydrocarbons

Urinary Metabolites of Polycyclic Aromatic Hydrocarbons and the Association with Lipid Peroxidation: A Biomarker-Based Study Between Los Angeles and Beijing.

Impaired lung function related to microenvironmental exposure to PAHs mixture in PM2.5: A repeated measurement study

Effects of single and combined urinary polycyclic aromatic hydrocarbon effects on lung function in the U.S. adult population

Risk of human exposure to polycyclic aromatic hydrocarbons: A case study in Beijing, China

Dietary and Inhalation Exposure to Polycyclic Aromatic Hydrocarbons and Urinary Excretion of Monohydroxy Metabolites – A Controlled Case Study in Beijing, China

Combustion-Derived Particulate PAHs Associated with Small Airway Dysfunction in Elderly Patients with COPD

Long-term exposure to PM1 is associated with increased prevalence of metabolic diseases: evidence from a nationwide study in 123 Chinese cities